Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 23, 2024 (Week 47)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 15,971 35,826 1,257,141 1,503,205
New England 637 1,111 41,894 49,143
Connecticut 114 296 8,288 11,989
Maine 44 81 2,410 2,693
Massachusetts 392 625 24,075 26,202
New Hampshire - 73 2,154 2,546
Rhode Island 73 389 3,858 4,522
Vermont 14 33 1,109 1,191
Middle Atlantic 1,517 4,247 165,003 181,924
New Jersey - 748 29,210 32,477
New York (excluding New York City) 652 933 35,305 38,634
New York City - 1,510 53,712 61,026
Pennsylvania 865 1,167 46,776 49,787
East North Central 1,604 4,459 157,230 206,092
Illinois 1 1,438 38,158 63,651
Indiana 469 722 28,421 31,016
Michigan 227 876 26,139 38,851
Ohio 669 1,153 44,381 49,847
Wisconsin 238 517 20,131 22,727
West North Central 881 1,987 78,912 88,775
Iowa 167 283 10,797 12,546
Kansas 154 288 10,477 12,209
Minnesota 86 486 17,712 19,787
Missouri 410 648 26,260 28,177
Nebraska - 208 7,217 8,433
North Dakota 60 87 2,764 3,134
South Dakota 4 108 3,685 4,489
South Atlantic 5,440 12,281 301,871 346,058
Delaware - 151 4,562 5,138
District of Columbia 94 178 6,137 7,666
Florida 1,715 6,933 97,030 102,460
Georgia 547 1,476 47,833 66,046
Maryland 598 956 28,278 32,708
North Carolina 4 1,437 49,303 60,278
South Carolina 1,731 820 31,063 30,055
Virginia 751 911 34,048 37,703
West Virginia - 103 3,617 4,004
East South Central 1,030 2,748 54,870 97,114
Alabama 584 884 28,312 30,424
Kentucky 348 592 14,762 15,378
Mississippi 98 1,006 11,796 17,743
Tennessee - 796 - 33,569
West South Central 892 4,646 178,127 204,334
Arkansas 189 399 14,428 16,325
Louisiana 412 750 30,609 33,060
Oklahoma 65 407 9,902 17,819
Texas 226 3,262 123,188 137,130
Mountain 1,173 2,431 93,883 105,455
Arizona 331 846 33,611 37,446
Colorado 231 747 21,620 23,218
Idaho 89 124 4,616 5,262
Montana 37 90 3,025 3,351
Nevada 236 344 13,159 14,315
New Mexico 80 229 7,864 10,117
Utah 169 239 9,067 10,064
Wyoming - 47 921 1,682
Pacific 2,797 4,838 185,351 224,310
Alaska 61 125 4,261 4,633
California 2,046 3,800 151,934 174,486
Hawaii - 115 - 5,757
Oregon 281 354 12,661 13,955
Washington 409 562 16,495 25,479
U.S. Territories - 113 667 4,768
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 113 667 4,768
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 2 4 49 47
Total 15,973 35,871 1,257,857 1,508,020
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.